Fidelity Investments’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-907,057
| Closed | -$16.1M | – | 4440 |
|
|
2018
Q3 | $16.1M | Buy |
907,057
+14,827
| +2% | +$255K | ﹤0.01% | 1775 |
|
|
2018
Q2 | $12.3M | Buy |
892,230
+489,099
| +121% | +$5.8M | ﹤0.01% | 1889 |
|
|
2018
Q1 | $3.66M | Sell |
403,131
-1,698,584
| -81% | -$9.37M | ﹤0.01% | 2249 |
|
|
2017
Q4 | $8.99M | Sell |
2,101,715
-342,377
| -14% | -$1.63M | ﹤0.01% | 1984 |
|
|
2017
Q3 | $3.45M | Sell |
2,444,092
-1,096,111
| -31% | -$1.53M | ﹤0.01% | 2226 |
|
|
2017
Q2 | $5.31M | Buy |
3,540,203
+31,168
| +0.9% | +$66.9K | ﹤0.01% | 2150 |
|
|
2017
Q1 | $9.02M | Buy |
3,509,035
+24,625
| +0.7% | +$57K | ﹤0.01% | 2002 |
|
|
2016
Q4 | $8.88M | Buy |
3,484,410
+23,670
| +0.7% | +$68K | ﹤0.01% | 2016 |
|
|
2016
Q3 | $10.7M | Sell |
3,460,740
-17,972
| -0.5% | -$56K | ﹤0.01% | 1959 |
|
|
2016
Q2 | $11.2M | Sell |
3,478,712
-112,287
| -3% | -$412K | ﹤0.01% | 1918 |
|
|
2016
Q1 | $11.1M | Buy |
3,590,999
+15,404
| +0.4% | +$50.3K | ﹤0.01% | 1913 |
|
|
2015
Q4 | $14.3M | Sell |
3,575,595
-3,320
| -0.1% | -$15.3K | ﹤0.01% | 1834 |
|
|
2015
Q3 | $16.4M | Sell |
3,578,915
-240,958
| -6% | -$1.26M | ﹤0.01% | 1728 |
|
|
2015
Q2 | $19.8M | Sell |
3,819,873
-1,101,850
| -22% | -$6.61M | ﹤0.01% | 1738 |
|
|
2015
Q1 | $30.8M | Sell |
4,921,723
-82,192
| -2% | -$474K | ﹤0.01% | 1563 |
|
|
2014
Q4 | $31.5M | Sell |
5,003,915
-105,008
| -2% | -$640K | ﹤0.01% | 1546 |
|
|
2014
Q3 | $31.1M | Sell |
5,108,923
-295,649
| -5% | -$2.02M | ﹤0.01% | 1535 |
|
|
2014
Q2 | $35.6M | Sell |
5,404,572
-693,720
| -11% | -$7.81M | ﹤0.01% | 1510 |
|
|
2014
Q1 | $145M | Buy |
6,098,292
+2,557,977
| +72% | +$37.1M | 0.02% | 784 |
|
|
2013
Q4 | $37.8M | Buy |
3,540,315
+323,500
| +10% | +$3.57M | 0.01% | 1449 |
|
|
2013
Q3 | $42.9M | Buy |
3,216,815
+1,270,774
| +65% | +$20.1M | 0.01% | 1364 |
|
|
2013
Q2 | $25.6M | Buy |
+1,946,041
| New | +$26.2M | ﹤0.01% | 1552 |
|
Other funds holding ECYT
Fidelity Investments's ECYT Position: Q4 2018 in Review
Fidelity Investments sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 907,057 shares — an estimated $16.1M sold.
Fidelity Investments first reported a position in ECYT in Q2 2013 and held it in 22 quarters. The position peaked at $145M in Q1 2014. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.
- Fidelity Investments reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
- Fidelity Investments sold 907,057 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $16.1M.
- Fidelity Investments first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 22 quarters.
- Fidelity Investments's Endocyte, Inc. Common Stock position peaked at $145M in Q1 2014.
- 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.
Based on Fidelity Investments's 13F filing for Q4 2018, filed 13 Feb 2019.